1. Home
  2. DAC vs OGN Comparison

DAC vs OGN Comparison

Compare DAC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$114.40

Market Cap

1.7B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.91

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAC
OGN
Founded
1972
1923
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
DAC
OGN
Price
$114.40
$6.91
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$105.00
$11.75
AVG Volume (30 Days)
72.7K
4.3M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
3.04%
1.11%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.65
P/E Ratio
$4.01
$10.01
Revenue Growth
N/A
N/A
52 Week Low
$65.40
$6.18
52 Week High
$118.83
$15.88

Technical Indicators

Market Signals
Indicator
DAC
OGN
Relative Strength Index (RSI) 66.22 36.26
Support Level $91.64 $6.48
Resistance Level N/A $7.74
Average True Range (ATR) 2.93 0.37
MACD 0.75 -0.08
Stochastic Oscillator 72.33 22.41

Price Performance

Historical Comparison
DAC
OGN

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: